SDG 9: MMV invests in partnerships, including those which strengthen capacity in Africa

MMV invests in partnerships, including those which strengthen research and manufacturing capacity in Africa.

Here are recent key milestones in this area: 

  • One pregnancy registry established in Kenya, with permission granted for expansion to Burkina Faso
  • Technology transfer resulted in the opening of a testing centre for resistance profiling in Burkina Faso
  • MMV has built an extensive network of over 400 partners in 50 countries since its inception in 1999
  • B&O Pharma selected as a manufacturing partner for low-dose primaquine for the prevention of relapse P. vivax malaria